A global eHealth company focused on improving respiratory patient adherence and remote monitoring, Adherium has raised $100K. The firm's Hailie® sensor technology and cloud-based data platform provide real-time feedback on inhaled medication use, helping manage difficult-to-treat asthma and COPD.
Adherium's solution, which has been clinically proven in over 85 studies involving 13,000 patients, has already seen more than 170,000 devices sold in 30 countries. The new capital is earmarked for a technology upgrade designed to access US reimbursement opportunities.















